SHANGHAI HENLIUS BIOTECH INC financial statements, including revenue, expenses, profit, and loss

The total revenue of 2696 for the last quarter is 1.59 B HKD, and it's 2.91% higher compared to the previous quarter. The net income of Q4 23 is 149.42 M HKD.